News
LADENBURG, Germany I May 27, 2025 I Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), ...
PARIS, France I May 27, 2025 I Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback